FDA Approves OLANZAPINE — Dr. Reddy's Laboratories Ltd.

# FDA Approves Dr. Reddy's Laboratories' Generic Olanzapine Dr. Reddy's Laboratories Ltd. received FDA approval for its generic olanzapine oral formulation on April 23, 2012, expanding treatment options in the competitive atypical antipsychotic market and allowing the company to capture market share from branded Zyprexa. The approval is expected to increase price competition and improve patient access to this widely prescribed medication for schizophrenia and bipolar disorder treatment.